Non-alcoholic fatty liver disease (NAFLD) constitutes a spectrum of disease states
characterized by hepatic steatosis and is closely associated to obesity and the metabolic …

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease worldwide. A significant proportion of patients with NAFLD develop a progressive …

Non-alcoholic steatohepatitis (NASH) is a chronic and progressive form of non-alcoholic
fatty liver disease. Its global incidence is increasing and makes NASH an epidemic and a …

There are 257 million persons worldwide with chronic hepatitis B virus (HBV) infection, a
leading causes of liver cancer. Almost all adults with acute HBV infection have a rapid …

Nonalcoholic fatty liver disease (NAFLD), recently renamed as metabolic (dysfunction)-
associated fatty liver disease (MAFLD), is a complex, multifactorial disease that progresses …

Objective In order to refine new therapeutic strategies in the pipeline for HBV cure,
evaluation of virological and immunological changes compartmentalised at the site of …

Mucosal-associated invariant T (MAIT) cells have been described in liver and non-liver
diseases, and they have been ascribed antimicrobial, immune regulatory, protective, and …

Mucosal-associated invariant T (MAIT) cells in HIV-1–infected individuals are functionally
impaired by poorly understood mechanisms. Single-cell transcriptional and surface protein …

According to the Centers for Disease Control and Prevention, chronic liver disease and
cirrhosis is the 11th leading cause of death in the United States. Common causes of chronic …

The innate system constitutes a first-line defence mechanism against pathogens. 80% of the
blood supply entering the human liver arrives from the splanchnic circulation through the …